About Bayer Pharmaceuticals Private Limited
Data last updated:
Bayer Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of Bayer South Asia Pte Ltd. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 29 July 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U05195MH1998PTC116021. Its GSTIN is 27AABCB3852F2ZV (Maharashtra). The company holds 27 GST registrations, of which 22 are active.
The company has an authorised share capital of ₹34.24 Cr and a paid-up capital of ₹21.32 Cr. It was formerly known as Bayer Zydus Health Care Private Limited. It is led by directors including Shweta Rai (Managing Director) and Manorama Chivukula (Person Incharge).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bayer House Central Avenue Hiranandani Estate Thane (West), Maharashtra, India – 400607.
As per the financials filed for FY 2023, the company reported a revenue of ₹597.4 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹35.58 Cr (net margin 6%) and EBITDA of ₹45.66 Cr (EBITDA margin 7.6%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years and 25% over five years.
The company has about 332 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹7.4 Cr on record. Court records list 30 cases involving the company, including 19 filed by the company and 11 filed against it; 6 cases are pending. The company has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹40 Cr; the latest was in March 2018. The company has 10 MSME Form 1 returns on record between 2019 and 2023, listing 77 overdue payments to 21 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bayer.in.
Company details
Contact details
Bayer Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is bayer.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressBayer House Central Avenue Hiranandani Estate Thane (West), Maharashtra, India – 400607
- IndustryPharma, Animal Pharmaceuticals & Healthcare, Drug Formulation & Development
To see the full contact details of Bayer Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bayer Pharmaceuticals Private Limited
FY 2025 filings availableBayer Pharmaceuticals Private Limited reported revenue of ₹597.4 Cr (up 25% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 25% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹597.4 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35.58 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | ||||
| Net Profit Margin | 6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bayer Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bayer Pharmaceuticals Private Limited
Bayer Pharmaceuticals has 4 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manorama Chivukula | Person Incharge | 22 Aug 2008 | 18 Years 2 Months | Current |
| Priya Murali | Person Incharge | 22 Aug 2008 | 18 Years 2 Months | Current |
| Shweta Rai Also directs: Bayer Zydus Pharma Private Limited | Managing Director | 01 Jan 2024 | 2 Years 9 Months | Current |
| Sunil Prakashlal Narwani | Director | 26 May 2025 | 1 Years 4 Months | Current |
Auditor
Bayer Pharmaceuticals Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2023 | 17366W/W-100018 |
Shareholding
The shareholding of Bayer Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bayer Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Dec 2000 | 90143188 | Hdfc Bank Limited | ₹3 Cr | Satisfied | |
| 13 Nov 2000 | 90143114 | Union Bank of India | ₹4 Cr | Satisfied | |
| 13 Nov 2000 | 90146136 | Union Bank of India | ₹40 Lakh | Satisfied |
To see the full charge records of Bayer Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Bayer Pharmaceuticals Private Limited has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹40 Cr; the latest was in March 2018.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Secondary share transfer | Undisclosed | Seller: Bayer Bioscience Private Limited |
| Mar 2015 | Secondary share transfer | Undisclosed | Seller: Covestro (India) Private Limited |
| Dec 2009 | Secondary share transfer | Undisclosed | Buyer: Bayer (South East Asia) Pte Limited Seller: Covestro (India) Private Limited |
| Dec 2008 | Secondary share transfer | Undisclosed | Seller: Covestro (India) Private Limited |
| Dec 2007 | Secondary share transfer | Undisclosed | Seller: Covestro (India) Private Limited |
To see the full deal history of Bayer Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bayer Pharmaceuticals Private Limited has 30 court cases on record: 19 filed by Bayer Pharmaceuticals, 11 filed against it. 6 cases are pending and 24 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 2 | 0 |
| High courts | 14 | 9 | 6 |
Cases on record (5 of 30)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Arbitration matter | Filed against the company by Amanta Healthcare Limited (Formerly Known As Mark Biosciences Limited) and 1 other | Disposed |
| District court, Ahmedabad, Gujarat | Court case (EXE R) | Filed by the company against M/S Amanta Healthcare Ltd. | Disposed |
| Bombay High Court | Criminal complaint | Filed against the company by And Innova Life Sciences Pvt. Ltd and 1 other | Disposed |
| District court, Vadodara, Gujarat | Court case (CR RA) | Filed by the company against Elysium Pharmaceuticals Ltd. and 10 others | Disposed |
| High Court, GUJARAT | Special civil application | Filed against the company by M/S Elysium Pharmaceuticals Limited and 1 other | Disposed |
To see the full case history of Bayer Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Bayer Pharmaceuticals Private Limited has 10 MSME Form 1 returns on record between 2019 and 2023, listing 77 overdue payments to 21 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 21)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Keyur Agency LLP | |||
| Splice Studioz | |||
| Saswad Tours and Travels Private Limited | |||
| Myka Enterprises |
To see the full MSME payment records of Bayer Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Bayer Pharmaceuticals Private Limited has a workforce of 332 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Bayer Pharmaceuticals has 27 GST registrations: 22 active and 5 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCB3852F2ZV | Maharashtra | Active | 01 Jul 2017 |
| 27AABCB3852F3ZU | Maharashtra | Active | 28 Jul 2017 |
| 02AABCB3852F1Z8 | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AABCB3852F1Z6 | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bayer Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bayer Pharmaceuticals Private Limited has 14 board changes on record since 2007: 4 appointments and 10 cessations. The latest: Sunil Prakashlal Narwani ceased to be Additional Director on 29 Sep 2025.
11 earlier events are in the company report.
News
Frequently asked questions
Bayer Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 29 July 1998 (28+ years old) and is registered under CIN U05195MH1998PTC116021.
Bayer Pharmaceuticals has 4 current directors:
- Shweta Rai - Managing Director
- Sunil Prakashlal Narwani - Director
- Manorama Chivukula - Person Incharge
- Priya Murali - Person Incharge
The latest financial statements of Bayer Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bayer Pharmaceuticals is 27AABCB3852F2ZV, registered in Maharashtra. The company has 27 GST registrations in all, of which 22 are active and 5 are cancelled or inactive. Other active GSTINs include 27AABCB3852F3ZU (Maharashtra), 02AABCB3852F1Z8 (Himachal Pradesh), 03AABCB3852F1Z6 (Punjab).
The CIN (Corporate Identification Number) of Bayer Pharmaceuticals is U05195MH1998PTC116021. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bayer Pharmaceuticals has 30 court cases on record: 19 filed by the company and 11 filed against it. 6 are pending. Most are in the district courts.
Bayer Pharmaceuticals was incorporated on 29 July 1998, making it 28+ years old. It is registered with the Registrar of Companies, Mumbai.
Bayer Pharmaceuticals has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹40 Cr; the latest was in March 2018.
Sunil Prakashlal Narwani ceased to be Additional Director on 29 Sep 2025. Sunil Prakashlal Narwani was appointed as Director on 26 May 2025. Kunal Jha ceased to be Additional Director on 09 Sep 2024. Bayer Pharmaceuticals has 14 board changes on record in total.
Bayer Pharmaceuticals has 10 MSME Form 1 returns on record between 2019 and 2023, listing 77 overdue payments to 21 micro and small suppliers. The latest return was filed on 17 Oct 2023.
Bayer Pharmaceuticals can be reached through the website bayer.in. Its registered office is in Thane, Maharashtra, India.